Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.4269/ajtmh.20-0903

http://scihub22266oqcxt.onion/10.4269/ajtmh.20-0903
suck pdf from google scholar
32815510!7543841!32815510
unlimited free pdf from europmc32815510    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32815510      Am+J+Trop+Med+Hyg 2020 ; 103 (4): 1360-1363
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic? #MMPMID32815510
  • Tesfaye W; Abrha S; Sinnollareddy M; Arnold B; Brown A; Matthew C; Oguoma VM; Peterson GM; Thomas J
  • Am J Trop Med Hyg 2020[Oct]; 103 (4): 1360-1363 PMID32815510show ga
  • The COVID-19 pandemic has brought concurrent challenges. The increased incidence of fake and falsified product distribution is one of these problems with tremendous impact, especially in low- and middle-income countries. Up to a tenth of medicines including antibiotics and antimalarial drugs in the African market are considered falsified. Pandemics make this worse by creating an ecosystem of confusion, distraction, and vulnerability stemming from the pandemic as health systems become more stressed and the workload of individuals increased. These environments create opportunities for substandard and falsified medicines to be more easily introduced into the marketplace by unscrupulous operators. In this work we discuss some of the challenges with fake or falsified product distribution in the context of COVID-19 and proposed strategies to best manage this problem.
  • |*Pandemics[MESH]
  • |Africa/epidemiology[MESH]
  • |Anti-Bacterial Agents/supply & distribution[MESH]
  • |Antimalarials/supply & distribution[MESH]
  • |Antiviral Agents/supply & distribution[MESH]
  • |Benchmarking/*legislation & jurisprudence[MESH]
  • |Betacoronavirus/*pathogenicity[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/diagnosis/*drug therapy/*epidemiology/virology[MESH]
  • |Counterfeit Drugs/analysis/*supply & distribution[MESH]
  • |Government Regulation[MESH]
  • |Humans[MESH]
  • |Pneumonia, Viral/diagnosis/*drug therapy/*epidemiology/virology[MESH]
  • |Public Health/ethics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box